Anzeige
Mehr »
Donnerstag, 05.03.2026 - Börsentäglich über 12.000 News
"Unbegrenzte Munition?" - Ohne diesen kritischen Rohstoff bleibt es wohl nur ein Versprechen
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: 896279 | ISIN: SE0000163628 | Ticker-Symbol: EJXB
Stuttgart
05.03.26 | 11:48
5,710 Euro
+6,13 % +0,330
Branche
Gesundheitswesen
Aktienmarkt
Sonstige
1-Jahres-Chart
ELEKTA AB Chart 1 Jahr
5-Tage-Chart
ELEKTA AB 5-Tage-Chart
RealtimeGeldBriefZeit
5,7355,76512:19
5,7305,76512:19
GlobeNewswire (Europe)
63 Leser
Artikel bewerten:
(0)

Elekta AB: Third quarter, November-January 2025/26

Third quarter

  • In constant exchange rates, net sales increased by 2 percent mainly driven by Europe and China. Reported sales in SEK decreased by 10 percent amounting to SEK 4,239 M (4,695).
  • The book-to-bill ratio was 1.17 (1.15), supported by strong order intake in China, U.S. and Europe.
  • Third quarter was impacted by a SEK 417 M restructuring charge related to change of the operating model, which is expected to reduce the cost base by more than SEK 500 M annually.
  • Higher adjusted gross margin of 38.3 percent (37.1) driven by product launches and improved pricing.
  • Tariff costs and changes in FX had a negative impact of 100 and 130 basis points respectively on the gross margin.
  • Adjusted EBIT amounted to SEK 504 M (548), resulting in a margin of 11.9 percent (11.7). The positive effect from the gross margin was partly offset by higher amortization and a lower capitalization level.
  • Net income was SEK 12 M (336) and basic earnings per share was SEK 0.03 (0.89).
  • Cash flow after continuous investments declined to SEK 255 M (730) in Q3 partly due to severance payments and lower contribution from working capital, while YTD amounted to SEK 251 M (-192).
Group summaryQ3
First nine months

SEK M2025/262024/25
2025/262024/25
Book-to-bill1.171.151% 1.081.08-1%
Net sales4,2394,695-10% 11,95512,860-7%
Net sales in constant exchange rates 2%1 2%1
Adjusted gross margin 238.3%37.1%1.3 ppts 37.8%36.8%1 ppts
Adjusted EBITDA 3820886-7% 2,0932,231-6%
Adjusted EBITDA margin 319.3%18.9%0.5 ppts 17.5%17.3%0.2 ppts
Adjusted EBIT 4504548-8% 1,1501,254-8%
Adjusted EBIT margin 411.9%11.7%0.2 ppts 9.6%9.8%-0.1 ppts
Gross margin35.1%36.9%-1.8 ppts 36.5%36.5%0 ppts
EBITDA403866-53% 1,6392,094-22%
EBITDA margin9.5%18.4%-8.9 ppts 13.7%16.3%-2.6 ppts
EBIT87525-83% 6961,087-36%
EBIT margin2.0%11.2%-9.1 ppts 5.8%8.5%-2.6 ppts
Net income12336-97% 346621-44%
Cash flow after continuous investments255730-475 251-192443
Adjusted earnings per share before/after dilution, SEK 50.88 / 0.880.94 / 0.94-7% 1.83 / 1.831.97 / 1.97-7%
Earnings per share before/after dilution, SEK 0.03 / 0.030.89 / 0.89-97% 0.91 / 0.911.63 / 1.63-44%

1Compared to last fiscal year based on constant exchange rates.
2Adjusted gross margin = Gross margin excluding items affecting comparability, see page 28.
3Adjusted EBITDA = EBITDA excluding items affecting comparability, see page 28.
4Adjusted EBIT = Operating income (EBIT) excluding items affecting comparability, see page 29.
5Adjusted earnings per share = Net income excluding items affecting comparability, attributable to Parent Company shareholders, in relation to the weighted average number of shares (excluding treasury shares), see page 30.

A solid quarter with significant impact from currency and restructuring

Third quarter summary
Net sales in Q3, at constant exchange rates, increased by 2 percent year-over-year, driven by continued positive momentum in Europe, as well as China's return to growth for the first time since Q3 2023/24. The book-to-bill ratio reached 1.17, supported by strong order intake in China and the U.S., as well as service orders in Europe.

The adjusted gross margin in Q3 improved year-over-year to 38.3 percent (37.1). The increase was mainly supported by product launches and improved pricing. The strengthening of the Swedish krona against major currencies and the depreciation of the U.S. dollar had an increasingly negative impact during the quarter, reducing gross margin by 130 basis points year-over-year. Adjusted EBIT margin for the third quarter ended at 11.9 percent (11.7). The improvement was primarily driven by a higher gross margin and lower R&D spend while increased amortization and lower capitalization of R&D weighed negatively by 150 basis points in total year-over-year on the EBIT margin.

Year-to-date operating cash flow after continuous investments amounted to SEK 251 M, representing an improvement of SEK 443 M compared with last year despite severance payments related to the change of operating model.

Value creation through speed and continuous improvement
As previously communicated, Elekta has defined four priority areas, our Must-Win Battles, that will drive value creation through increased speed and continuous improvement. Through Must- Win Battle 1, we are implementing a new operating model aimed at simplifying and decentralizing the organization. As a result, we expect to achieve more than SEK 500 M in annualized cost savings, with the full effect realized in Q1 2026/27. The implementation of the new operating model is progressing well, with more than 80 percent of the planned workforce reductions already completed.

With Must-Win Battle 2, Focused Innovation, we aim to improve returns on R&D investment by sharpening our focus on projects that address commercial demand and shape the future of radiation therapy through our focus on adaptive treatments.

Winning in the U.S. and expanding in China are the priority areas included in Must-Win Battle 3. In the U.S., the launch of Evo and Elekta ONE have strengthened our product offering across hardware, software, and service with continued strong interest from customers. Expanding our presence in China represents the second pillar of this Must-Win Battle. To strengthen our competitiveness, we are further deepening the localization of Elekta's portfolio and supply chain. We have maintained our market-leading position through a period of declining demand, and as the market begins to recover, we expect to see operating leverage from the Chinese business.

Must-Win Battle 4 focuses on reducing cost of goods sold and reinforcing our ambition to expand the gross margin, thereby freeing up resources for continued innovation. Key initiatives include introducing dual sourcing and cost efficient suppliers, deploying AI-tools to support field service engineers, improving order fulfillment efficiency, and simplifying installation and serviceability.

Outlook
We reiterate our full-year 2025/26 outlook, where we expect net sales in constant currency to grow year-over-year. Furthermore, we expect continuous negative impact on earnings from FX at current exchange rates and tariffs. On June 17, we will host a Capital Markets Day in Stockholm.

Jakob Just-Bomholt
President and CEO

This information is information that Elekta AB (publ) is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact persons set out above, at 2026-03-05 07:30 CET.

© 2026 GlobeNewswire (Europe)
Favoritenwechsel - diese 5 Werte sollten Anleger im Depot haben!
Das Börsenjahr 2026 ist für viele Anleger ernüchternd gestartet. Tech-Werte straucheln, der Nasdaq 100 tritt auf der Stelle und ausgerechnet alte Favoriten wie Microsoft und SAP rutschen zweistellig ab. KI ist plötzlich kein Rückenwind mehr, sondern ein Belastungsfaktor, weil Investoren beginnen, die finanzielle Nachhaltigkeit zu hinterfragen.

Gleichzeitig vollzieht sich an der Wall Street ein lautloser Favoritenwechsel. Während viele auf Wachstum setzen, feiern Value-Titel mit verlässlichen Cashflows ihr Comeback: Telekommunikation, Industrie, Energie, Pharma – die „Cashmaschinen“ der Realwirtschaft verdrängen hoch bewertete Hoffnungsträger.

In unserem aktuellen Spezialreport stellen wir fünf Aktien vor, die genau in dieses neue Marktbild passen: solide, günstig bewertet und mit attraktiver Dividende. Werte, die nicht nur laufende Erträge liefern, sondern auch bei Marktkorrekturen Sicherheit bieten.

Jetzt den kostenlosen Report sichern – bevor der Value-Zug 2026 endgültig abfährt!

Dieses exklusive PDF ist nur für kurze Zeit gratis verfügbar.
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.